On June 21st, the EU-TRAIN project hosted its final hybrid workshop at Paris Santé Campus, gathering around 50 experts in kidney transplantation, including industry representatives, researchers, clinicians, and patient associations. The event focused on non-invasive monitoring techniques, precision medicine, and the future of kidney transplant care.

Key highlights included presentations on emerging biomarkers as donor-derived cell-free DNA (dd-cfDNA) and cell-based functional assays to predict graft rejection in kidney transplantation. The workshop also featured a roundtable discussion with kidney transplant patients, emphasizing the importance of patient perspectives in shaping future strategies.

The workshop marked a significant step forward in improving kidney transplant outcomes through innovation and collaboration.

Valentin Goutaudier, from the INSERM team, presented his work ‘Detection of kidney allograft rejection using blood biomarkers: Results of the European multicenter prospective EU-TRAIN trial (NCT03652402)’ at the #ESOTcongress 2023 in Athens.

He was also awarded with the ‘Digital Transformation in Transplantation Best Abstract Award’ for his work in the Banff Automation System, recently published in Nature Medicine.

Congratulations to the team!

#EUTRAIN

EU-TRAIN participates to the Transplant Live platform of the European Society for Organ Transplantation (ESOT).

Transplant Live is the online education platform  that aims to offer high-quality, easily accessible education opportunities to the transplant community worldwide.

Start exploring now and learn more about the educational opportunities offered by Transplant Live > Here.

During this syposium an educational activity endorsed by the EU-TRAIN consortium about “Development, validation and reporting a prediction model” was carried out and was attended by 50 participants from different European Countries. The course was chaired by EU-TRAIN principal investigators Profs Alexandre Loupy and Oriol Bestard, who coordinated the session and facilitated the smooth running of the course.

EU-TRAIN and ESOT gave the opportunity to 3 students to visit for 15 days the three main laboratories of the consortia, which were involved in the develop of the main biomarkers of the project (ICS Barcelona, CHU Nantes and Inserm Paris).

In that congress, a state-of-the-Art session as well as an educational symposium were devoted to Artificial Intelligence tackling the main goals of the EU-TRAIN consortium as a new approach to analyse outcomes and surrogates in transplantation.

The first EU TRAIN – ESOT symposium is a unique opportunity to “get on board” the EU-TRAIN, the European Transplantation and Innovation Consortium for Risk Stratification in Kidney Transplant Patients. The symposium will not only introduce the consortium, but it will also focus on the methodological and statistical pitfalls clinical researchers can face in the field of transplantation.

At the symposium that takes place on Sunday 15 September 2019, the future of biomarker-guided patient care in solid organ transplantation will be further exposed as well as how the consortium will create a molecular platform for precision diagnostics, data integration and analytics. Eventually, it will provide a platform of discussion on how to network and set up a European Consortium specifically directed to the younger audience.